Members |
targetComponentId |
Hemangiopericytic meningioma |
Solitary fibrous tumor |
Hemangiopericytoma |
Solitary fibrous tumor |
Hemangiopericytoma, benign |
Solitary fibrous tumor and hemangiopericytoma grade 1 (morphologic abnormality) |
Hemangiopericytoma, malignant |
Solitary fibrous tumor and hemangiopericytoma grade 3 (morphologic abnormality) |
Hemarthrosis NOS |
Hemarthrosis |
Hemarthrosis of other site, NEC |
Hemarthrosis |
Hemarthrosis of other specified site |
Hemarthrosis |
Hematocrit - PCV - NOS |
Hematocrit determination |
Hematological agents adverse reaction |
Adverse reaction to drug |
Hematology NOS |
Haematology test |
Hematology finding |
Hematology report (record artifact) |
Hematology finding |
Hematology report (record artifact) |
Hematology finding abnormal |
Haematology test outside reference range |
Hematoside |
GM3-ganglioside |
Hematuria NOS |
Blood in urine |
Hemoglobin F-Calluna |
Hemoglobin F-Heather |
Hemoglobin F-Iwata |
Hemoglobin F-Minoo |
Hemoglobin F-Kuala Lumpur |
Hemoglobin F-Urumqi |
Hemoglobin F-Siena |
Hemoglobin F-Carlton |
Hemoglobin F-Yamaguchi |
Hemoglobin F-Marietta |
Hemoglobin J-Kaohslung |
Haemoglobin J-Kaohsiung |
Hemoglobin J-Nayanza |
Haemoglobin J-Nyanza |
Hemoglobin S |
Hemoglobin S |
Hemoglobin S disease |
Sickle cell-hemoglobin SS disease |
Hemoglobin S disease with crisis |
Hemoglobin SS disease with crisis (disorder) |
Hemoglobin S disease without crisis |
Hemoglobin SS disease without crisis (disorder) |
Hemoglobin estimation NOS |
Hemoglobin level estimation |
Hemoglobin variant NOS |
Hemoglobin variant test |
Hemoglobin very high |
Hemoglobin above reference range |
Hemoglobin very low |
Hemoglobin below reference range (finding) |
Hemolysis |
Hemolysis |
Hemolytic disease NOS |
Hemolytic disorder |
Hemolytic disease due to other isoimmunization, NEC |
Hemolytic disease of the newborn due to non-ABO, non-Rh isoimmunization |
Hemolytic uremic syndrome |
Hemolytic uremic syndrome |
Hemoquant feces |
Evaluation of stool specimen |
Hemorrhage NOS |
Bleeding |
Hemorrhage control by packing NOS |
Packing for haemorrhage |
Hemorrhage due to any device, implant AND/OR graft |
Bleeding |
Hemorrhagic fever with renal syndrome |
Hemorrhagic fever with renal syndrome (disorder) |
Hemorrhagic nephroso-nephritis |
Hemorrhagic fever with renal syndrome (disorder) |
Hemorrhoidectomy by injection |
Destruction of hemorrhoids by sclerotherapy |
Hemorrhoids NOS |
Hemorrhoids |
Hemorrhoids with other complications NOS |
Hemorrhoids |
Hemorrhoids without complication |
Hemorrhoids |
Hemostasis of unspecified organ |
Control of hemorrhage |
Hepadnavirus |
Family Hepadnaviridae (organism) |
Heparin 100unt |
Product containing heparin (medicinal product) |
Heparin 10unt |
Product containing heparin (medicinal product) |
Heparin cofactor I |
Antithrombin III |
Heparin sodium 100 unt/mL solution |
Heparin (as porcine heparin sodium) 100 unit/mL solution for injection |
Heparin sodium 1000iu/sodium chloride 0.9% infusion solution ampule |
Product containing only heparin in parenteral dose form (medicinal product form) |
Heparin sodium 10u/mL injection solution ampule |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
Heparin sodium 10unt/mL solution |
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection |
Heparin sodium in 0.9% sodium chloride 1000iu/500mL infusion |
Product containing only heparin in parenteral dose form (medicinal product form) |
Hepatectomy |
Excision of liver (procedure) |
Hepatic colic |
Biliary colic |
Hepatitis |
Inflammatory disease of liver |
Hepatitis B group virus |
Genus Orthohepadnavirus (organism) |
Hepatitis B immunoglobulin 1000iu powder for injection solution vial |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
Hepatitis B immunoglobulin 200iu powder for injection solution vial |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
Hepatitis B immunoglobulin 500iu powder for injection solution vial |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
Hepatitis B screening test |
Hepatitis B screening |
Hepatitis B screening test |
Hepatitis B screening |
Hepatitis B screening test |
Hepatitis B screening |
Hepatitis b immune globulin 217u injection solution vial |
Hepatitis B surface antigen immunoglobulin-containing product in parenteral dose form |
Hepatitis b immune globulin 312units/mL injection solution 1mL vial |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
Hepatitis b immune globulin 312units/mL injection solution 5mL vial |
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection |
Hepatitis caused by Toxoplasma |
Hepatitis caused by Toxoplasma gondii |
Hepatitis non-A non-B |
Viral hepatitis |
Hepatitis panel |
Hepatitis panel measurement |
Hepatocerebral encephalopathy |
Hepatic encephalopathy |
Herbaspirillum rubrisualbicans |
Herbaspirillum rubrisubalbicans (organism) |
Hereditary disease |
Hereditary disease |
Hereditary endotheliopathy, retinopathy, nephropathy, stroke syndrome |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
Hereditary malignant neuroendocrine neoplasm of small intestine |
Hereditary well-differentiated neuroendocrine tumor of small intestine (disorder) |
Hereditary methemoglobinemia, enzymatic type |
Autosomal recessive congenital methemoglobinemia (disorder) |
Hereditary nephrogenic diabetes insipidus |
Hereditary vasopressin resistance |
Hereditary nonspherocytic hemolytic anemia due to aldolase A deficiency |
Glycogen storage disease due to aldolase A deficiency (disorder) |
Hereditary nonspherocytic hemolytic anemia due to reduced nicotinamide adenine dinucleotide-methemoglobin reductase deficiency |
Autosomal recessive congenital methemoglobinemia (disorder) |
Hereditary progressive muscular dystrophy |
Muscular dystrophy |
Hereditary sensory-motor neuropathy, type V |
Hereditary motor and sensory neuropathy type 5 (disorder) |
Hereditary site-specific ovarian cancer syndrome |
Hereditary breast and ovarian cancer syndrome (disorder) |
Hereditary thrombocytopenia NEC |
Hereditary thrombocytopenic disorder (disorder) |
Hereditary vascular retinopathy |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
Hermansky-Pudlack syndrome |
Hermansky-Pudlak syndrome |
Hermaphroditism |
Ovotesticular disorder of sex development |
Hermaphroditism |
Ovotesticular disorder of sex development |
Heroin - non-pharmaceutical |
Diamorphine (substance) |
Herpailurus yaguarondi |
Puma yagouaroundi (organism) |
Herpes simplex - other |
Herpes simplex |
Herpes simplex - other |
Herpes simplex |
Herpes simplex with complication |
Herpes simplex |
Herpes simplex with other specified complications |
Herpes simplex |
Herpes simplex with unspecified complications |
Herpes simplex |
Herpes simplex without complication |
Herpes simplex |
Herpes zoster with complication |
Herpes zoster |
Herpes zoster with nervous system complication |
Herpes zoster |
Herpes zoster with ophthalmic complication |
Herpes zoster ophthalmicus |
Herpes zoster with other central nervous system complication |
Herpes zoster |
Herpes zoster with other central nervous system complication |
Herpes zoster |
Herpes zoster with other central nervous system complication NOS |
Herpes zoster |